Glioblastoma Disables the Brain's Inhibitory Off Switch to Fuel Its Own Growth

Researchers at Baylor College of Medicine have uncovered a mechanism by which glioblastoma may drive its own expansion. In animal models, the tumor weakens GABA-mediated inhibition of surrounding brain circuits through two molecules, GAT-1 and DBI, producing hyperexcitability that in turn promotes tumor growth. The causality was tested from both directions: removing GAT-1 accelerated tumor growth, while activating inhibitory neurons near the tumor slowed it; conversely, blocking those neurons pushed growth even faster. The work positions neuronal inhibition as a potential therapeutic lever in glioblastoma. Where things stand: the findings are preclinical, drawn from animal models, and no clinical translation has yet been reported. Open questions include which of the identified targets could be drugged safely in patients and how the mechanism behaves in the human disease.

Written by a model from the reports · updated 4 hours ago